Skip to main content

UBS Group AG

Position in IMCR — Immunocore Holdings plc

CIK 1610520 ZURICH, V8

Position in IMCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$415,956
-$854,383 QoQ
Shares Held
13,101
-68.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in IMCR Over Time

Shares Held

Position Value (USD)

Derivatives in IMCR

reported options exposure · as of Jun 30, 2023
CallValue
$1,798,800
CallShares
30,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. IMCR ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMCR

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $415,956 13,101
2026-03-31 $1,270,339 42,134
2025-12-31 $250,535 7,218
2025-09-30 $1,498,029 41,234
2025-06-30 $707,680 22,552
2025-03-31 $5,225,835 176,132
2024-12-31 $4,150,827 140,706
2024-09-30 $1,360,972 43,719
2024-06-30 $447,313 13,199
2024-03-31 $863,200 13,280
2023-12-31 $89,430 1,309
2023-09-30 $76,707 1,478
2023-06-30 $1,798,800 30,000
2023-06-30 $112,483 1,876
2023-03-31 $3,450,912 69,800
2023-03-31 $207,648 4,200
2023-03-31 $81,821 1,655
2022-12-31 $736,203 12,900
2022-12-31 $239,694 4,200
2022-12-31 $373,750 6,549
2022-09-30 $277,978 5,922
2022-09-30 $197,148 4,200
2022-06-30 $264,751 7,096
2022-03-31 $251,399 8,408
2021-12-31 $323,395 9,445
2021-09-30 $519,017 14,001
2021-06-30 $469,146 12,014
2021-03-31 $496,919 11,673